DK3468535T3 - Resveratrol-solubiliseringsprodukt til farmakologiske formål - Google Patents

Resveratrol-solubiliseringsprodukt til farmakologiske formål Download PDF

Info

Publication number
DK3468535T3
DK3468535T3 DK17702347.0T DK17702347T DK3468535T3 DK 3468535 T3 DK3468535 T3 DK 3468535T3 DK 17702347 T DK17702347 T DK 17702347T DK 3468535 T3 DK3468535 T3 DK 3468535T3
Authority
DK
Denmark
Prior art keywords
resveratrol
pharmacological purposes
solubilization product
solubilization
product
Prior art date
Application number
DK17702347.0T
Other languages
English (en)
Inventor
Dariush Behnam
Marshall A Hayward
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquanova Ag filed Critical Aquanova Ag
Application granted granted Critical
Publication of DK3468535T3 publication Critical patent/DK3468535T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17702347.0T 2016-06-14 2017-01-26 Resveratrol-solubiliseringsprodukt til farmakologiske formål DK3468535T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2016063579 2016-06-14
PCT/EP2017/051659 WO2017215791A1 (en) 2016-06-14 2017-01-26 Resveratrol solubilisation product for pharmaceutical purposes

Publications (1)

Publication Number Publication Date
DK3468535T3 true DK3468535T3 (da) 2020-07-06

Family

ID=57944408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17702347.0T DK3468535T3 (da) 2016-06-14 2017-01-26 Resveratrol-solubiliseringsprodukt til farmakologiske formål

Country Status (9)

Country Link
US (1) US10780056B2 (da)
EP (1) EP3468535B1 (da)
JP (1) JP6907243B2 (da)
CN (1) CN109562066B (da)
DK (1) DK3468535T3 (da)
ES (1) ES2798403T3 (da)
HU (1) HUE049304T2 (da)
PL (1) PL3468535T3 (da)
WO (1) WO2017215791A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102228135B1 (ko) * 2018-07-19 2021-03-16 조선대학교산학협력단 레스베라트롤을 포함하는 고형 제제 형태의 약학 조성물 및 레스베라트롤의 가용화 방법
US20230075521A1 (en) * 2021-08-20 2023-03-09 Jupiter Neurosciences, Inc. Resveratrol pharmaceutical compositions and methods of use thereof
CN113812552B (zh) * 2021-09-01 2023-12-26 江南大学 一种全营养固体饮料
EP4678167A1 (en) * 2024-07-04 2026-01-14 Laboratorio della Farmacia S.p.A. Solid oral composition with gradual enteric release for lipophilic active ingredients
US12599569B1 (en) * 2024-12-30 2026-04-14 King Saud University Encapsulated resveratrol (RSV) nanoparticles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103211806B (zh) * 2003-05-27 2015-09-09 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物及其用途
US20060270732A1 (en) * 2005-05-26 2006-11-30 Suracell, Inc. Antioxidant supplement compostion and method of use
CN101874763A (zh) * 2009-04-29 2010-11-03 上海家化联合股份有限公司 一种白藜芦醇柔性脂质体及其制备方法
CA2863544C (en) * 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
KR20140071913A (ko) * 2012-12-04 2014-06-12 삼성정밀화학 주식회사 식품 조성물 및 이를 포함하는 연질 캡슐
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US9861611B2 (en) * 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

Also Published As

Publication number Publication date
EP3468535A1 (en) 2019-04-17
JP2019518047A (ja) 2019-06-27
PL3468535T3 (pl) 2020-09-07
WO2017215791A1 (en) 2017-12-21
US10780056B2 (en) 2020-09-22
HUE049304T2 (hu) 2020-09-28
US20190307700A1 (en) 2019-10-10
CN109562066B (zh) 2021-08-10
ES2798403T3 (es) 2020-12-11
CA3026810A1 (en) 2017-12-21
JP6907243B2 (ja) 2021-07-21
CN109562066A (zh) 2019-04-02
EP3468535B1 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
HUE052145T2 (hu) Aeroszolképzõ eszköz
SI3457851T1 (sl) Derivati sobetiroma
DK3034285T3 (da) Tætningsmiddeldispenser
FI20145090A7 (fi) Kuitupohjainen tuote
HRP20190336T1 (hr) Derivati 6-alkinilpiridina kao smac-mimetici
EP3498467C0 (en) FOAM PRODUCT
EP3444945A4 (en) OSCILLATOR
HUE049304T2 (hu) Rezveratrol szolubilizációs termék gyógyászati célokra
EP3960133C0 (en) ORTHOTIC PRODUCT
EP3380144C0 (en) DRUG ADMINISTRATION DEVICES
HUE054207T2 (hu) Új immunbiológiai termékek
DK3307076T3 (da) Podepartikelprodukt
DK3257589T3 (da) Dyse
HUE053397T2 (hu) A rezveratrol szolubilizációja
EP3554960A4 (en) BABY BOTTLE
CN303248952S (zh) 跟焦器
BR112016025074A2 (pt) produto de espuma
DE112017003750A5 (de) Kolben-Zylinder-Einheit
CL2017000619S1 (es) Boquilla
UA34570S (uk) Пляшка
UA34392S (uk) Пляшка
UA34118S (uk) Пляшка
UA34296S (uk) Пляшка
UA34622S (uk) Пляшка
ES1149784Y (es) Dispensador